News
LSBCF
0.037
NaN%
--
Weekly Report: what happened at LSBCF last week (0504-0508)?
Weekly Report · 3d ago
Weekly Report: what happened at LSBCF last week (0427-0501)?
Weekly Report · 05/04 10:21
LakeShore Biopharma Slashes Merger Price in Amended Going-Private Deal
TipRanks · 04/29 12:33
Weekly Report: what happened at LSBCF last week (0420-0424)?
Weekly Report · 04/27 10:24
Weekly Report: what happened at LSBCF last week (0413-0417)?
Weekly Report · 04/20 10:20
Weekly Report: what happened at LSBCF last week (0406-0410)?
Weekly Report · 04/13 10:24
Weekly Report: what happened at LSBCF last week (0330-0403)?
Weekly Report · 04/06 10:24
Weekly Report: what happened at LSBCF last week (0323-0327)?
Weekly Report · 03/30 10:24
LakeShore Biopharma Weighs Cut‑Price Take‑Private Bid After RMB576.5 Million Arbitration Hit
TipRanks · 03/25 12:50
Weekly Report: what happened at LSBCF last week (0316-0320)?
Weekly Report · 03/23 10:21
Weekly Report: what happened at LSBCF last week (0309-0313)?
Weekly Report · 03/16 10:20
Weekly Report: what happened at LSBCF last week (0302-0306)?
Weekly Report · 03/09 10:20
Weekly Report: what happened at LSBCF last week (0223-0227)?
Weekly Report · 03/02 10:19
Weekly Report: what happened at LSBCF last week (0216-0220)?
Weekly Report · 02/23 10:19
Weekly Report: what happened at LSBCF last week (0209-0213)?
Weekly Report · 02/16 10:19
Weekly Report: what happened at LSBCF last week (0202-0206)?
Weekly Report · 02/09 10:21
LakeShore Biopharma’s Buyer Group Challenges Merger After RMB576.5 Million Arbitral Hit, Forcing EGM Delay
TipRanks · 02/06 12:48
Weekly Report: what happened at LSBCF last week (0126-0130)?
Weekly Report · 02/02 10:21
LakeShore Biopharma Faces Disputed RMB500 Million Arbitration Awards Amid Fraud Investigation
TipRanks · 01/29 12:44
Weekly Report: what happened at LSBCF last week (0119-0123)?
Weekly Report · 01/26 10:20
More
Webull provides a variety of real-time LSBCF stock news. You can receive the latest news about LakeShore Biopharma Co., Ltd through multiple platforms. This information may help you make smarter investment decisions.
About LSBCF
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.